Reva Medical Financial Data

Company name:REVA Medical IncStatus:Active
End of fiscal year:December 30 2017ISINAU000000RVA3
Auditor:Grant Thornton LLPYear established:1998
Company sector name:HealthcareTrading currency:AUD
Industry name:Medical DevicesIndustry group nameMedical Devices
Doing business in:United States (US)Address5751 Copley Drive, 92111
Tel.:+1 858 966-3000City/Country:San Diego, United States
Fax:+1 858 966-3099Web address:http://www.revamedical.com
Company description:REVA Medical Inc is a development stage medical device company. Its primary focus is the development of drug-eluting bioresorbable coronary scaffolds for the treatment of cardiovascular disease. The company operates through the development and commercialization of medical devices segment. Its product portfolio comprised of Fantom Sirolimus-Eluting Bioresorbable Scaffold, proprietary polymer family, optimal drug delivery, and clinical program.
Price Price change [%] Bid Offer Open High Low Volume
0.17  0.00[0.0%] 0.175 0.19 0.00
Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
71.0792542 414.79877 0.87 0.02 - 10.00 - - - -

RVA KEY FIGURES (at previous day's close)

Yesterday's Close
0.17
PE Ratio
10.00
Market Capitalisation
71.08M
Latest Shares Outstanding
414.80M
Earnings pS (EPS)
0.02
Dividend pS (DPS)
-
Dividend Yield
-
Sales per Employee
882.35
Effective Tax Rate
-
Foreign Sales
-
Domestic Sales
-
Selling, General & Adm/tive (SG...
19,048.89%
Research & Devlopment (R&D) as ...
0.00%
Gross Profit Margin
6.67%
EBITDA Margin
33,080.00%
Pre-Tax Profit Margin
15,853.33%
Assets Turnover
-
Return on Assets (ROA)
0.44%
Return on Equity (ROE)
-
Return on Capital Invested (ROC...
-
Current Ratio
7.98
Leverage Ratio (Assets/Equity)
-
Interest Cover
2.23
Total Debt/Equity (Gearing Rati...
-
LT Debt/Total Capital
-
Working Capital pS
0.05
Cash pS
0.04
Book-Value pS
0.05
Tangible Book-Value pS
0.00
Cash Flow pS
-0.05
Free Cash Flow pS
-0.05
Spread
0.02
Gross gearing
0.00%
Net Debt
-18.54M

RVA Balance Sheet Chart (December 30 2017)

:assets
Period † High Low
1 Week0.000.00
1 Month0.000.00
3 Months0.000.00
6 Months0.000.00
1 Year0.000.00
3 Years0.680.12
5 Years1.350.12

Share price performance previous 3 years

Share price performance intraday

Period † Open Open Avg. VWAP Min Vol Max Vol Avg. Daily Vol Change %
1 Week0.000.000.000.000.000.000.000.0%
1 Month0.000.000.000.000.000.000.000.0%
3 Months0.000.000.000.000.000.000.000.0%
6 Months0.000.000.000.000.000.000.000.0%
1 Year0.000.000.000.000.000.000.000.0%
3 Years0.640.3289380.30758544,393,61693,098-0.47-73.44%
5 Years0.800.7724510.76692514,393,61685,350-0.63-78.75%

RVA Growth Ratios (December 30 2017)

1 year 3 years 5 years 10 years
Diluted EPS growth
-
-
-
-
Diluted continuous EPS growth
-
-
-
-
Dividend growth
-
-
-
-
Equity per share growth
-
-
-
-
Revenue growth
-
-
-
-
Operating income growth
-
-
-
-
Net income growth
-
-
-
-
Net income cont growth
-
-
-
-
CFO growth
-
-
-
-
FCF growth
-
-
-
-
Operating revenue growth
-
-
-
-

RVA Income Statement December 30 2017 (USD)

Total Revenue
0.045
Operating Revenue
0.045
Cost of Revenue
0.042
Gross Profit
3,000.00
Operating Expenses
21.332
Selling,General and Administr...
8.572
Research and Development
12.76
Operating Income
-21.329
Interest Income/Expense,Net-N...
-6.633
Interest Income-Non Operating
0.057
Interest Expense-Non Operatin...
6.69
Other Income/Expense,Net
35.096
Gain on Sale of Securities
35.211
Special Income/Charges
-0.115
Pretax Income
7.134
Net Income Available to Commo...
7.134
Net Income
7.134
Net Income Including Noncontr...
7.134
Net Income from Continuing Op...
7.134
Average Dilution Earn
-28.47
DilutedNIAvailtoComStockholde...
-21.336
Basic EPS
0.02
Basic EPS from Continuing Ope...
0.02
Basic EPS from Discontinued O...
0.00
Diluted EPS
-0.04
Diluted EPS from Continuing O...
-0.04
Diluted EPS from Discontinued...
0.00
Basic Weighted Average Shares...
418.11326
Diluted Weighted Average Shar...
533.17482
TotalOperatingIncomeAsReporte...
-21.329
Total Expenses
21.374
Net Income from Continuing an...
7.134
Normalized Income
-27.962
Basic EPS,Continuing and Disc...
0.02
Diluted EPS,Continuing and Di...
-0.04
Interest and Dividend Income
0.057
Interest Expense
6.69
Net Interest Income
-6.633
Earning Before Interest and T...
13.824
Earning Before Interest Tax D...
14.886
Cost of Revenue,Reconciled
0.042
Depreciation,Reconciled
1.062
Net Income from Continuing Op...
7.134
TotalUnusualItemsExcludingGoo...
35.096
TotalUnusualItems
35.096
Normalized Basic EPS
-0.07
Normalized Diluted EPS
-0.11
NormalizedEBITDA
-20.21
Tax rate for calculations
0.00
TotalRevenueAsReported
0.045
OperatingExpenseAsReported
21.332

RVA Efficency Ratios (December 30 2017)

Days in sales
511.00
Days in inventory
5,448.93
Days in payment
6,665.60
Cash conversion cycle
-705.67
Receivable turnover
0.71
Inventory turnover
0.07
Payable turnover
0.05
Fixed assets turnover
0.02
Assets turnover
0.00
ROE
-
ROA
0.44
ROIC
-
FCF sales ratio
-
FCF net income ratio
-
Capital expenditure sales ratio
8.58

RVA Financial Health Ratios (December 30 2017)

Current ratio
7.98
Quick ratio
7.57
Debt total capital ratio
-
Debt equity ratio
-
Financial leverage
-
Total debt to equity
-

RVA Avearge Growth Ratios Over 5 Years (December 30 2017)

Growth ann capital spending
-0.28
Growth ann gross profit
-
Avg gross margin
-
Avg post tax margin
-
Avg pre tax marginr
-
Avg net profit
-
Avg ret commonr
-
Avg ret assets
-1.83
Avg ret invested capital
-

RVA Profitability Ratios (December 30 2017)

Gross margin
0.07
Operating margin
-473.98
EBT margin
158.53
Tax rate
-
Net margin
158.53
Sales per employee
882.35
EBIT margin
307.20
EBITDA margin
330.80
Normalized net profit margin
-621.38
Interest coverage
2.07
Inc per employee tot ops
139,882.35

RVA Valuation Ratios (December 28 2017)

Sales per share
-
Growth ann sales per share 5 ye...
-
Book value per share
-0.29
CF per share
-0.05
Price to EPS
75.76
Ratio PE 5 year high
150.31
Ratio PE 5 year low
12.25
Price to book
-
Price to sales
-
Price to cash flow
-
Price to free cash flow
-
Div rate
-
Dividend yield
-
Div payout tot ops
-
Div payout 5 year
-
Payout ratio
0.00
Sustainable growth rate
-
Cash return
-0.05

RVA Balance Sheet December 30 2017 (USD)

Total Assets
22.661
Current Assets
21.142
Cash,Cash Equivalents,and Sho...
20.014
Cash and Cash Equivalents
18.544
Short Term Investments
1.47
Receivables
0.063
Accounts Receivable
0.063
Inventories
0.627
Raw Materials
0.255
Work-in-Process
0.061
Finished Goods
0.329
Inventories Adjustments/Allow...
-0.018
Prepaid Assets and Others
0.438
Total Non-Current Assets
1.519
Net Property,Plant,and Equipm...
1.492
Gross Property,Plant,and Equi...
8.728
Properties
0.00
Machinery,Furniture/Equipment
6.306
Leasehold and Improvements
2.422
Accumulated Depreciation
-7.236
Other Non-Current Assets
0.027
Total Liabilities
115.474
Current Liabilities
2.651
Payables and Accrued Expenses
1.197
Payables
0.793
Accounts Payable
0.756
Taxes Payable
0.037
Accrued Expenses,Current
0.404
Pension and Other Post-Retire...
1.296
Deferred Liabilities,Current
0.158
Deferred Revenue,Current
0.158
Total Non-Current Liabilities
112.823
Long Term Debt and Capital Le...
99.368
Long Term Debt
99.368
Accrued Expenses,Non-Current
8.779
Derivative Liabilities
4.176
Other Non-Current Liabilities
0.5
Total Equity
-92.813
Stockholder's Equity
-92.813
Capital Stock
4,000.00
Common Stock
4,000.00
Additional Paid in Capital
289.342
Retained Earnings
-382.157
Accumulated Gains/ Losses Not...
-2,000.00
Total Capitalization
6.555
Common Stock Equity
-92.813
Net Tangible Assets
-92.813
Working Capital
18.491
Invested Capital
6.555
Tangible Book Value
-92.813
Total Debt
99.368
NetDebt
80.824
Ordinary Shares Number
41.24582
TotalLiabilitiesAsReported
115.474
TotalEquityAsReported
-92.813

RVA Cash Flow December 30 2017 (USD)

Cash Flow from Operating Acti...
-18.858
Cash Flow from Continuing Ope...
-18.858
Net Income from Continuing Op...
7.134
Operating Gains/Losses
-35.159
Gain/Loss on Sale of Property...
0.052
Gain/Loss on Investment Secur...
0.52
Depreciation,Amortization and...
1.062
Depreciation and Amortization
1.062
Stock-Based Compensation
2.047
Other Non-Cash Items
6.69
Changes in Working Capital
-0.632
Change in Receivables
-0.063
Changes in Account Receivable...
-0.063
Change in Inventories
-0.57
Change in Prepaid Assets
0.084
Change in Payables and Accrue...
-0.508
Change in Payables
-0.072
Change In Account Payable
-0.072
Change in Accrued Expenses
-0.436
Change in Other Working Capit...
0.425
Cash Flow from Investing Acti...
-1.856
Cash Flow from Continuing Inv...
-1.856
Purchase/Sale of Property,Pla...
-0.386
Purchase of Property,Plant an...
-0.386
Purchase/Sale of Investments,...
-1.47
Purchase of Investments
-1.47
Cash Flow from Financing Acti...
32.584
Cash Flow from Continuing Fin...
32.584
Issuance/Payments of Debt,Net
44.985
Issuance/Payments of Long Ter...
44.985
Issuance/Payments of Common S...
-12.401
Proceeds or Issuance of Commo...
0.092
Payments for Common Stock
-12.493
Cash and Cash Equivalents,End...
18.544
Change in Cash
11.87
Cash and Cash Equivalents,Beg...
6.674
Capital Expenditure
-0.386
Issuance of Capital Stock
0.092
Repurchase of Capital Stock
-12.493
Free Cash Flow
-19.244
ChangeinCashSupplementalAsRep...
11.87
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201128 17:47:53